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The properties of GABA receptor-mediated responses 
were examined in noncultured astrocytes, acutely isolated 
from the mature rat hippocampus. Whole-cell patch clamp- 
ing revealed a GABA-activated Clf conductance that was 
mimicked by the GABA, receptor agonist muscimol and 
depressed by the GABA, antagonists bicuculline and pic- 
rotoxin. The GABA,-activated currents were potentiated by 
the barbiturate pentobarbital and the benzodiazepine di- 
azepam. The benzodiazepine inverse agonist DMCM either 
enhanced or depressed the astrocytic GABA,-mediated re- 
sponses, suggesting receptor heterogeneity with respect 
to pharmacologic profiles. In addition, GABA evoked an in- 
crease in [Ca2+le measured by indo-l fluorometry, which 
was depressed in the presence of verapamil or picrotoxin. 
A GABA,-induced depolarization, therefore, causes Ca*+ 
influx through voltage-gated Ca2+ channels. The expres- 
sion and subcellular localization of GABA, receptors and 
its subunits were examined using immunohistochemical 
and fluorescent benzodiazepine binding techniques. Poly- 
clonal antisera raised against the GABAJbenzodiazepine 
receptor, which recognizes multiple subunit isoforms, la- 
beled receptors on the astrocytic cell body and most large 
processes. In contrast, antisera generated against either CX, 
or p, subunit peptides revealed immunoreactivity predom- 
inantly on a subset of processes. To determine the sub- 
cellular distribution of membrane-bound receptors, a fluo- 
rescent benzodiazepine derivative was superfused over 
live astrocytes and visualized with laser-scanning confocal 
microscopy. Specific fluorescence was distributed in dis- 
crete clusters on the cell soma and a subset of distal pro- 
cesses. Collectively, these data support the view that as- 
trocytes, like neurons, express GABA, receptors and target 
subunit isoforms to distinct cellular localizations. Astro- 
cytic GABA, receptors may be involved in both [Cl-], and 
[pH], homeostasis, and a GABA-evoked increase in [Ca2+li 
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could serve as a signal between GABAergic neurons and 
astrocytes. 
[Key words: astrocyte, GABA receptor, Cl- current, ben- 
zodiazepines, barbiturates, voltage-activated Ca2+ influx, 
Western blot, immunocytochemistry, ligand binding] 
Electrophysiological studies indicate that cultured astrocytes and 
oligodendrocytes express receptors for GABA (reviewed by 
Blankenfeld and Kettenmann, 1992; Fraser et al., 1994). The 
astrocytic GABA, receptor shares many pharmacological prop- 
erties with the neuronal receptor, including modulation by bar- 
biturates, benzodiazepines, and steroids. GABA, receptor-me- 
diated responses have also been recorded from astrocytes in 
hippocampal (MacVicar et al., 1989; Steinhauser et al., 1993, 
1994) and retinal (Clark and Mobbs, 1992) slices, oligodendro- 
cytes in corpus callosum slices (Berger et al., 1992) Bergmann 
glia in cerebellar slices (Mtlller et al., 1994) and stellate glia in 
the intact pituitary pars intermedia (Mudrick-Donnon et al., 
1993). Although the functional aspects of GABA, receptor ac- 
tivation on astrocytes is not known, further investigations of the 
physiologic, pharmacologic, and anatomic properties of these 
receptors may lead to a more clear understanding of their func- 
tion in the CNS. 
Recently, a procedure for acute isolation of astrocytes from 
mature tissue was described (MacVicar et al., 1992; Tse et al., 
1992). By using this preparation, not only is the possibility of 
culture artifact avoided, but agonists can be applied rapidly and 
uniformly, which is not possible in whole tissue. For example, 
saturating concentrations of GABA were required to activate 
glia receptors embedded in tissue slices and, thus, the dose- 
response relation and allosteric modulation could not be deter- 
mined accurately (e.g., Berger et al., 1992; Steinhauser et al., 
1993, 1994). The first objective of this study was, therefore. to 
confirm the presence of GABA, receptors on acutely isolated 
astrocytes and to investigate the electrophysiologic and phar- 
macologic properties of these receptors using whole-cell patch 
clamp and rapid perfusion techniques. 
In most neurons, activation of GABA, receptors causes an 
influx of Cl- and a membrane hyperpolarization (Alvarez-Leef- 
mans and Russels, 1990). In contrast, activation of glial GABA, 
receptors, in both oligodendrocytes and astrocytes, always leads 
to an efflux of Cl- (Hoppe and Kettenmann, 1989; MacVicar et 
al., 1989). In glia, the nonpassive distribution of Cll is based 
on the activity of two inwardly directed Cll transporters: an 
Na+/K+/2Cll cotransporter and a Cl-/HCO-, exchanger (Ket- 
tenmann, 1990; Kimelberg, 1990). Studies have shown that the 
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Cl- equilibrium potential in astrocytes can be as positive as -35 
mV, leading to a membrane depolarization of -40 mV following 
GABA, receptor activation (Kettenmann and Schachner, 1985). 
A GABA,-induced membrane depolarization of this magnitude 
would surpass the activation threshold for voltage-gated Ca*+ 
channels which have been identified in cultured (MacVicar, 
1984; MacVicar and Tse, 1988; Barres et al., 1989) and acutely 
isolated (Duffy and MacVicar, 1994) astrocytes. It is not known, 
however, whether GABA,-induced membrane depolarizations 
cause a change in [Ca”],. It is possible that a GABA,-induced 
increase in [Ca*+li, which has been reported recently for cultured 
glial precursor cells (Kirchhoff and Kettenmann, 1992), could 
result in activity-dependent modification of astrocytic signaling 
pathways. The second objective of this study was, therefore, to 
measure [Ca”], with indo-l fluorometry to determine whether 
GABA,-induced membrane depolarization evokes Ca*+ influx 
through voltage-gated Ca2+ channels. 
Knowledge of the subcellular distribution of GABA, recep- 
tors within single astrocytes is important for determining the 
functional aspects of receptor expression. For example, GABA, 
receptors may be targeted and expressed on astrocytic processes, 
which are in close association with synaptic regions (Peters et 
al., 1991). Molecular cloning and low-stringency screening of 
cDNA libraries have identified at least 1.5 GABA, receptor sub- 
units separated by degree of homology into five families (o(,-~, 
Blil, yIm3, 6, p; reviewed by Olsen and Tobin, 1990; Burt and 
Kamatchi, 1991). Recombinant studies revealed further that sub- 
unit combinations differ in sensitivity from agonists and allo- 
steric modulation. In astrocytes, sequence- and subunit-specific 
antibodies could reveal the expression of particular subunits and 
their isoforms which join to construct functional GABA, recep- 
tors. The third objective of this study was, therefore, to deter- 
mine the expression and subcellular distribution of GABAJben- 
zodiazepine receptors and their subunits using polyclonal 
antibodies and a novel fluorescent benzodiazepine derivative. 
The results demonstrate that GABA, receptors with unique 
pharmacologic profiles are expressed in mature astrocytes, that 
GABA, receptor activation depolarizes astrocytes sufficiently to 
open voltage-gated Ca*+ channels, and that GABA, receptors 
and subunits are targeted to distinct cellular locations. 
This work has been presented in abstract form (Fraser et al., 
1992, 1993). 
Materials and Methods 
Acute isolation of hippocampal astrocytes. The isolation technique for 
hippocampal astrocytes has been described previously (MacVicar et al., 
1992; Tse et al., 1992). Briefly, transverse hippocampal slices (500 pm) 
were obtained from Sprague-Dawley rats (2-6 weeks postnatal) and 
placed in artificial cerebrospinal fluid (aCSF) containing (in mM) 124 
NaCl, 5 KCl, 1.3 MgCl,, 2 CaCl,, 26 NaHCO,-, and 10 D-glucose (pH 
7.35; 280 mOsm). Slices were transferred to-a magnetic s&ring flask 
filled with 30 ml of aCSF containing naoain (24-28 U/ml: Sigma. 
P-4762), the papain activator L-cysteiiex(i mg/lOO U papain’; Siima: 
C-1276), and 1 mu kynurenic acid (Sigma, K-3375). During enzymatic 
digestion, the solution was stirred continuously and aerated with 95% 
0,/5% CO,. Following the 1 hr enzymatic treatment, the slices were 
washed several times with fresh aCSF and stored at room temperature 
in aCSE When needed, the CA1 region was dissected free and me- 
chanically triturated with fire-polished Pasteur pipettes in HEPES-buf- 
fered DMEM which contained 0.1 mu leupeptin (Sigma, L-2884) and 
1 mM kynurenic acid. Isolated cells in suspension were allowed to either 
settle onto poly-L-lysine-coated coverslips for 20 min or bind securely 
to poly-L-lysine-coated coverslips by brief centrifugation before the on- 
set of constant superfusion with selected external solutions. 
ElectrophysioZogicaZ recording. Patch electrodes were pulled from 
1.5 mm o.d. thin-walled glass (TW 150F-4, World Precision Instru- 
ments) on a Flaming-Brown micropipette puller (P-87, Sutter Instru- 
ment Company). Electrodes had a tip resistance of 4-8 MR when tested 
in the external solution. The various K+ conductances of the cell mem- 
brane (Tse et al., 1992) were suppressed by using an intracellular so- 
lution containing (in mM) 130 CsCl. 4 M&l,. 1 CaCl,. 10 HEPES. 10 
EGTA, and 2 Mg;+-ATP’(pH 7.2) in combination withan extracellular 
solution containing (in mu) 119 NaCl, 3 CsCl, 2 MgCl,, 2 CaCl,, 5 
BaCl,, 10 D-glucose, and 10 HEPES (pH 7.35). Intracellular Ca*+ con- 
centration was calculated to be - 11 nM. In some experiments, NaCl 
was substituted with equimolar Na+-gluconate to shift the Cl- equilib- 
rium potential. Current recordings were obtained using a single elec- 
trode amplifier (Axopatch-IA) in voltage-clamp mode, and filtered 
(four-pole Bessel) at a low-pass bandwidth of 200 Hz (-3 dB). Analog 
current waveforms were displayed and digitized simultaneously by 
PCLAMP software via a Tl-125 A/D interface (Axon Instruments). Liquid 
junction potentials between electrode and bath solutions were measured 
and compensated subsequently. All recordings were performed at room 
temperature (-21°C) and data is reported as the mean ? standard error. 
Drug application. Drugs were applied to single cells in the extracel- 
lular solution described above by a rapid perfusion system consisting 
of multiple stainless steel inlet pipes (id. 0.43 mm) secured in a tri- 
angular-shaped plexiglass head with one common outlet pipe (i.d. 0.33 
mm). The plexiglass head was mounted on a hydraulic manipulator via 
a 10 cm shaft and positioned within 0.5-1.0 mm of the cell to insure a 
uniform flow of solution across the entire membrane. Control and drug- 
containing solutions were gravity fed from multiple reservoirs (60 ml 
syringes) through consecutively smaller polyethylene tubing (from id. 
1.14 mm to id. 0.58 mm) to the inlet pipes. The tubing containing 
control solution was split by a “normally open” solenoid valve (Lee 
Co., LFYA0518232Hj, whereas tubing containing drugs was split by 
“normallv closed” solenoid valves (Lee Co.. LFVX0500250A). The 
cell was ‘bathed continuously by a rapidly flowing stream of control 
solution between drug applications. Rapid solution changes were 
achieved by simultaneously closing the control valve and opening a 
drug valve. Each valve was controlled by a solenoid driver coupled to 
a TTL-pulse from the A/D interface. 
Fborometric measurement of intracellular Ca2+. Intracellular Ca*+ 
([Ca*+],) changes were monitored by measuring indo-l fluorescence. 
Astrocytes were loaded with dye by adding 50 pg indo-l/AM (Molec- 
ular Probes, I-1203; sonicated with 10 p,l DMSO and 10% pluronic 
acid) to the trituration media. The period during which the cells were 
initially dissociated and allowed to settle was sufficient for dye loading. 
Once adhered to the cover slip, astrocytes were superfused with aCSE 
Single astrocytes were illuminated at 380 nm and the fluorescence out- 
puts at 405 and 485 nm were measured simultaneously using a dichroic 
mirror and two photomultiplier tubes (PMT, Hamamatsu, C1053-01). 
Illumination frequency (l-2 Hz) and duration (50 msec) were controlled 
by an electronic shutter (UniBlitz). PMT current output was converted 
to voltage and digitized at 200 Hz using a Tl-125 A/D interface and 
AXOTAPE software (Axon Instruments). Following each experiment, au- 
tofluorescence was determined by superfusion of 1 mM MnZ+ in the 
presence of the nonfluorescent Ca 2+ ionophore 4-bromo A-23187 (1 
PM; Molecular Probes, B-1494). Intracellular Ca*+ concentration was 
estimated by the equation from Grynkiewicz et al. (1985): 
where K, is 250 nm, R,,, is 0.2, R,,, is 3.0, and S/S, was 10.667. All 
values except for Kd were determined experimentally on our recording 
setup using calibrated Ca2+ solutions. Drugs were applied by changing 
the superfusion in the bath. The perfusion rate was approximately 1.0 
ml/min, which allowed a complete solution change in the bath (volume 
150 pl) in <30 sec. 
Antibody production. A polyclonal antibody which recognizes the 
GABAJbenzodiazepine receptor complex was generated against the af- 
finity-purified GABA, receptor. Purification of the protein was carried 
out on a benzodiazepine affinity column according to Sigel et al. (1982). 
One hundred to three hundred micrograms of the purified receptor was 
injected into the lymph nodes of New Zealand White rabbits. 
Subunit-specific antibodies were generated in New Zealand White 
rabbits immunized with peptides corresponding to the N and C termini 
of the ~1, and p, subunits. The following subunit-specific sequences 
were (Y, N-terminus, Q-P-S-L-Q-D-E-L-K-D-N-T-T-V-F-C; ~1, C-ter- 
minus, C-L-N-R-E-P-Q-L-K-A-P-T-P-H-Q; B, N-terminus, H-S-A-N-E- 
P-S-N-M-S-Y-V-K-E-T-V-C; p, C-terminus, L-F-N-V-V-Y-W-L-Y-V-H- 
C. Peptides were coupled to rabbit serum albumin (RSA) with 
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glutaraldehyde (Chow et al., 1984) and by reacting the C-terminal cys- 
teine residue with succinimidyl-phenyl-maleimide (Gitman et al., 1985). 
Rabbits were injected at multiple intradermal sites with 1 mg of the 
conjugated peptide in the RIB1 adjuvant system (RIB1 Immunochem., 
Hamilton, MN). 
For all antibodies, booster injections were performed every 2-3 
weeks. The animals were exsanguinated after 10 weeks of the initial 
immunization. Immunoglobulin fractions (IgG) were precipitated in sat- 
urated ammonium sulfate, dialyzed against phosphate buffer, and stored 
at -20°C. IgG fractions were assayed for recognition of the GABA, 
receptor by dot blots and Western blotting of affinity-purified GABA,/ 
benzodiazepine receptors and crude glycoproteins from rat brain. 
Western blot analysis. Purified GABA, receptors or crude glycopro- 
teins were electrophoresed on 4-15% or 7.5% linear gradient polyacryl- 
amide SDS gels, respectively, according to the method of Laemmli 
(1970). Gels were silver stained or electrophoretically transferred to 
nitrocellulose by the method of Towbin et al. (1979). Nitrocellulose 
membranes containing the transferred proteins were blocked with 5% 
nonfat dry milk in TBST [lo mM Tris-HCl, pH 8.0,0.15 M NaCl, 0.02% 
Tween-20 (Sigma, P-1379)] and incubated with several dilutions of the 
antibodies in the same buffer at 4°C overnight. Blots were then washed 
three times with fresh TBST and incubated with alkaline phosphatase 
conjugated to goat-anti-rabbit IgG (Promega) for 2 hr at room temper- 
ature. The blots were washed twice in TBST, rinsed with water, and 
developed with p-nitrotetrazolium blue chloride (0.1 mg/ml; Sigma) and 
5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt (0.005 mg/ml; 
Pierce). 
Glycoprotein fractions used for immunoblotting were obtained from 
rat brain by chromatography on a wheat germ agglutinin Sepharose-4B 
column @GA-Sepharose-4B). Briefly, rat brain-was homogenized in 
10 mM Tris-HCl (uH 7.4) with 300 mu sucrose. This homogenate was 
centrifuged at 1060 X g for 12 min, and the supernatant ientrifuged 
again at 27,000 X g for 35 min. The pellet obtained was resuspended 
and homogenized in the same buffer without sucrose, and centrifuged 
as before. The final pellet was homogenized in 10 mM Tris-HCl (pH 
7.4), 2.5% Triton X-100, and 150 mM KCl, shaken for 30 min, and 
centrifuged at 100,000 X g for 60 min. The supernatant obtained con- 
tained the solubilized proteins that were applied to a WGA-Sepharose 
4B chromatography column. Glycoproteins were eluted from the col- 
umn with 25 mM N-acetylglucosamine. Fractions were assayed by SH- 
flunitrazepam binding to determine fractions that contained the GABA,/ 
benzodiazepine receptor. Nonspecific binding was measured in the 
presence of 300 nM clonazepam. 3H radioactivity was counted in Scin- 
tiverse on a Beckman LS-1801 Scintillation Counter. In all steps, a 
cocktail of protease inhibitors (Sigma) was used, which contained io- 
doacetamide (I miw), o-phenanthroline (1 mM), leupeptin (1 mM), apro- 
tinin (1 mM), and pepstatin (0.5 mglml). 
fmmunocytochemistry. Isolated cells, adhered securely to coverslips, 
were fixed with 4% paraformaldehyde in phosphate-buffered saline 
(PBS) for 10 min at room temperature. Membranes were permeabilized 
with 95% EtOH/5% acetic acid for 10 min at - 10°C. A mouse mono- 
clonal antibody directed against glial fibrillary acidic protein (MAb- 
GFAP, 1: 100; Boehringer Mannheim) and one of the rabbit polyclonal 
antibodies generated against the GABA,/benzodiazepine receptor (PAb- 
967, 1: l OO-250), an CK, subunit peptide (PAb-B, 1: loo), or a p, subunit 
peptide (PAb-Q, 1:lOO) were applied together in PBS containing 10% 
normal goat serum, 3% bovine serum albumin, and 0.05% Tween-20 
for 2 hr at 37°C. Antigen/antibody complexes were visualized by in- 
cubation of coverslips in fluorescein-conjugated goat antibody to mouse 
IgG (1: 100; Jackson) and rhodamine-conjugated goat antibody to rabbit 
IgG (1:lOO; Jackson). All steps were separated by five 10 min washes 
in PBS containing 0.05% Tween-20. Coverslips were then mounted with 
Fluorosave (Calbiochem Inc.) on glass slides and viewed with a Nikon 
microscope equipped with appropriate filter sets. Images were scanned 
in RGB (1000 dpi; Leafscan 35) from Kodachrome color film, con- 
verted to a black/white scale, and final output produced by a Linotronic 
printer. Controls at the immunohistochemical level included omission 
of primary antibodies or replacement of polyclonal antibodies with 
preimmune sera. 
Fluorometric mapping of GABA/benzodiazepine receptors. A flue- 
rescent benzodiazepine derivative was prepared by alkylation of the 
amide on Ro 7-1986 by BODIPY alkyl halide. This compound main- 
tains high affinity and specificity for central benzodiazepine receptors 
and has been characterized previously by mass spectrometry, equilib- 
rium binding to brain membranes, and fluorescence microscopy (Velaz- 
quez et al., 1989; McCabe et al., 1990). Astrocytes, adhered securely 
to coverslips, were placed in the perfusion chamber on an upright laser- 
scanning confocal microscope (Meridian Instr., Inc.). Once an astrocyte 
had been identified visually by its distinct morphology, the chamber 
was perfused with 5 nM of the BODIPY-Ro 7-1986 derivative in phos- 
phate-buffered saline (PBS) for 20 min. Total binding was determined 
following a 2 min wash with PBS. Nonspecific binding was determined 
as above, with the exception that the derivative was coperfused with 
500 nM diazepam. All binding experiments were performed at reduced 
temperatures (<8”C) to suppress endocytosis of the derivative. Fluores- 
cent images from cells were obtained with a silicon-intensified target 
camera (SIT, Hamamatsu, C2400) through a 40X, 0.75 numerical ap- 
erture, water-immersion objective (Zeiss). Video frames were averaged 
and digitized into a 512 X 480 pixel array by an eight-bit A/D board 
of an image processor (Series 15 1; Imaging Technology Inc.) controlled 
by a personal computer (Packard-Bell 386). Digital images were en- 
hanced by thresholding and histogram stretching; pixel intensities were 
determined by averaging. At the completion of the binding experiments, 
a subset of cells was fixed and stained for GFAP to verify its astrocytic 
phenotype. 
Results 
Identijcation and characteristics of astrocytes 
Acutely isolated astrocytes from the hippocampal CA1 region 
are known to be immunoreactive for GFAP (MacVicar et al., 
1992; Tse et al., 1992), the predominant protein of intermediate 
filaments in astroglia. They were identified visually by distinct 
morphological features, including a small soma diameter (-8 
pm) and bushy processes with random orientation. In contrast, 
pyramidal neurons and interneurons were easily recognized by 
their larger smooth cell bodies and l-3 tapering dendrites (e.g., 
Kay and Wong, 1986; Fraser and MacVicar, 1991). Neurons 
isolated simultaneously do not stain for GFAP (Tse et al., 1992). 
Identification of cell type can also be inferred by membrane 
current patterns evoked by voltage steps or capacitance mea- 
surements obtained via a calibrated potentiometer. In astrocytes, 
inward Na+ currents were not observed under whole-cell voltage 
clamp (Fig. 1) and action potentials could not be generated in 
the current-clamp mode (data not shown). In contrast, neurons 
coisolated with astrocytes exhibited robust inward transient and 
sustained currents carried by Na+ and Ca*+/Ba*+, respectively 
(Fig. 1). Typically, the larger astrocytic surface area was reflect- 
ed by large capacitance values (61 + 3 pF, range 25-100 pF, II 
= 65/77; 12 cells could not be estimated because of values 
> 100 pF), whereas neurons had smaller values (12 t 1 pE 
range 4-21 pE IZ = 32). 
GABA-activated membrane currents 
In all pyramidal neurons (n = 32) and 91% of astrocytes (n = 
77/85), application of GABA activated an inward current when 
the membrane potential was voltage clamped at -80 mV (Fig. 
1). At a GABA concentration of 50 pM, the peak inward current 
amplitude in pyramidal neurons and astrocytes was 1562 2 146 
pA (range 791-2500 pA, n = 14) and 486 ? 38 pA (range 38- 
2000 pA, n = 50), respectively. In both cell types, the current 
activated quickly, followed by marked desensitization. 
The peak amplitudes of both neuronal and astrocytic GABA- 
activated currents were concentration dependent. To reveal the 
dose-response relation for both cell types, variable concentra- 
tions of GABA (1, 3, 10, 30, 100, 300, 1000 FM) were applied 
for 3 set at 5 min intervals (Fig. 2). This delay was sufficient 
for full recovery from desensitization. The peak amplitude of 
GABA responses was plotted as a function of GABA concen- 
tration, normalized to a saturating response elicited by 1 mM 
GABA. The peak current amplitude evoked by 1 mM GABA 
was 2078 t 349 pA for pyramidal neurons (range 679-4000 
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Figure 1. Membrane current patterns and GABA-activated inward 
currents in acutely isolated CA1 pyramidal neurons and astrocytes as 
revealed by whole-cell patch clamp. AI, A pyramidal neuron was iden- 
tified by its characteristic morphology and typical neuronal current pat- 
tern when voltage clamped to hyper- and depolarizing membrane po- 
tentials (see Materials and Methods for description of solutions). 
Depolarization revealed a large amplitude transient inward current and 
a smaller sustained inward current.-The whole-cell capacitance was 16 
UE A2, Ranid aunlication of 50 U,M GABA to the neuron in Al evoked 
an inward current of 2000 pA when voltage clamped at -80 mV. Bl, 
An acutely isolated astrocyte was identified by its characteristic mor- 
phology and passive membrane response when voltage clamped to hy- 
per- and depolarizing membrane potentials (see Materials and Methods 
for description of solutions). The whole-cell capacitance was 63 pE B2, 
Rapid application of 50 PM GABA to the astrocyte in Bl evoked an 
inward current of 500 pA when voltage clamped at -80 mV. 
pA, n = 9) and 1064 t 167 pA for astrocytes (range 275-2050 
pA, n = 12). Responses ignificantly above the noise level could 
be elicited with l-3 FM GABA and the current amplitude in- 
creased in a sigmoidal fashion with the GABA concentration 
(Fig. 2C). The dose-response relations were in agreement with 
the conventional expression 
IIImax = l/(1 + (EC,,I[GABA])“, 
where I is the amplitude of the GABA-activated current, EC,, 
is the GABA concentration which evokes the half-maximal re- 
sponse, and IZ is the Hill coefficient. The EC,, and hill coefficient 
values for neurons were 14 FM and 1.1, whereas astrocytes had 
values of 50 pM and 1.6. The maximal current amplitudes and 
EC,, values suggested that GABA acting at neuronal receptors 
had greater potency and efficacy. The hill coefficient values sug- 
gested that the astrocytic receptors must bind a minimum of two 
GABA molecules to open the receptorlionophore, whereas the 
receptors on pyramidal neurons have only one binding site or 
slight allosteric interaction between two putative sites (Bormann 
and Clapham, 1985). 
Reversal potential of the GABA-activated current 
The ionic species permeating the astrocytic GABA receptor/ion- 
ophore was identified by analyzing the reversal potential of the 
GABA-induced current (Fig. 3). Two strategies were employed 
to vary the membrane potential. First, the membrane potential 
0.0 l - l 





0.0 1, &;t’. ,,._,, ,,,,,, ,,,,,, 
10.’ 1O-6 1o-5 1O-4 1o-3 
GABA Concentration [Ml 
Figure 2. Dose-response relation of neuronal and astrocytic GABA- 
activated inward currents. A, Rapid application of 3, 10, or 30 PM 
GABA to a CA1 pyramidal neuron revealed inward currents of increas- 
ing amplitude from a holding potential of -80 mV. These concentra- 
tions represent the linear por&n of the concentration-response curve. 
The whole-cell cauacitance was 5 oE B. Raoid aoulication of 10. 30. 
or 100 pM GABAto an astrocyte re;ealed inward &rents of increasing 
amplitude from a holding potential of -80 mV. These concentrations 
represent the linear portion of the concentration-response curve. The 
whole-cell capacitance was 52 pE C, The dose-response relation for 
the neuronal and astrocytic GABA-evoked inward current, in which the 
peak current at variable concentrations was normalized to the maximal 
response obtained with 1 mu GABA. Each point represents the mean 
+ SEM from three cells. 
was altered to steady-state levels of -80, -60, -40, -20, 0, 
20, 40, and 60 mV for several seconds followed by a rapid 
application of GABA (Fig. 3A; IZ = 4). The current induced by 
50 FM GABA reversed in polarity close to 0 mV. Second, the 
membrane potential was ramped from - 100 to 100 mV over 4 
set (Fig. 3B). To resolve the GABA-activated current, the ramp- 
induced current in standard bathing solution was subtracted from 
that obtained in the presence of 50 pM GABA (Fig. 3C). The 
GABA current reversed at 1.0 ? 1.8 mV (range -3-7 mV, IZ 
= 5). These values coincided with the expected Cl- equilibrium 
potential (E,, = 0 mV) as derived by the Nernst equation. More- 
over, decreasing the [Cl-], concentration to 90 and 55 mM, by 
substitution with the nonpermeable anion gluconate, shifted the 
reversal potential to 12.6 2 0.8 (range 11-14 mV, IZ = 3) and 
22.3 + 1.5 (range 20-25 mV, n = 3) mV, respectively (Fig. 
30). These values are in close agreement with the calculated 
Cl- equilibrium potentials of 11 and 24 mV. These data indicate 
that GABA activates a Cl- conductance in acutely isolated as- 
trocytes, indicating the expression of GABA, receptors. 
Pharmacological properties of the GABA response 
The GABA-activated current recorded from acutely isolated as- 
trocytes was characterized further by testing drugs affecting GA- 
BAA-mediated responses as described in other cells. To ensure 
a stable response, several GABA-activated currents were mon- 
itored before and after application of a particular drug. Consec- 
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Figure 3. The reversal potential of the GABA-activated inward cur- 
rent in astrocytes corresponds to the equilibrium potential of Cl- (E,, 
= 0 mV). A, GABA-activated currents at variable membrane potentials 
as indicated. The current reversed in polarity close to 0 mV. The whole- 
cell capacitance was 64 pE B, A computer-generated ramp paradigm 
changed the membrane potential from - 100 to 100 mV in control and 
in the presence of 50 FM GABA. Note the incompletely blocked inward 
and outward rectification characteristic of astrocytes. C, The GABA- 
activated current was obtained by subtracting the curve obtained in 
control from the curve obtained in the presence of GABA. The current 
reverses close to 0 mV. The whole-cell capacitance was 100 pE D, The 
reversal potential for the GABA-activated current, obtained as described 
in B and C, for different extracellular Cl- concentrations. The straight 
line represents the Cl- equilibrium potential as calculated by the Nernst 
equation. Each point represents the mean ? SEM from 3-5 cells. 
utive tests were separated by 5 min. The GABA, receptor ag- 
onist muscimol (50 pM) mimicked the GABA-induced response 
(Fig. 4A). The amplitude of the muscimol response, however, 
was enhanced with respect to GABA by 45 ? 15% (range 6- 
93%, n = 5). Coapplication of GABA and 10 FM of the GABA, 
receptor antagonist bicuculline or 10 pM of the Cl- channel 
blocker picrotoxin depressed the GABA responses by 79 + 15% 
(range 48-96%, IZ = 3) or 74 + 11% (range 52-86%, n = 3), 
respectively (Fig. 4B,C). Depression of the GABA-induced cur- 
rent was reversible upon washout of the antagonists. This set of 
experiments indicates that the GABA-induced inward current is 
caused by the activation of GABA, receptors. 
The pharmacological properties of the astrocytic GABA, re- 
ceptor were characterized by testing the effect of GABA, re- 
ceptor modulators, namely the barbiturate pentobarbital, the ben- 
zodiazepine diazepam and the benzodiazepine inverse agonist 
DMCM. Similar to neurons, sodium pentobarbital (25 pM; Fig. 
5A) and diazepam (10 PM; Fig. 5B) potently and reversibly en- 
hanced the astrocytic GABA-activated current by 159 ? 51% 
(range 42-315%, n = 5) and 56 + 14% (range 18-260%, n = 
17), respectively. Surprisingly, DMCM either potentiated (15 + 
4%, range 7-25%, IZ = 3/15; Fig. 5C) or depressed (19 & 3%, 
range 8-40%, n = 12/15; Fig. 5D) the astrocytic GABA-acti- 
vated current, indicating heterogeneity with respect to receptor 
expression. In contrast, GABA-activated currents recorded in 
A 50@4GABA 50 pM muscimol 50 PM GABA 
2 I I , , - 
B 50pMGABA 50 pM GABA+lO pM bicuculline 50 FM GABA 
d -2 t , - 
1 f--I- 1 I- 
c 50pM GABA 50 FM GABA+lO PM picrotoxin 50 )IM GABA 
Figure 4. Pharmacological characteristics of the astrocytic GABA cur- 
rent suggest a GABA, receptor. A, Rapid application of 50 PM GABA 
evoked control currents that were similar to those evoked by 50 FM 
muscimol, a specific GABA, receptor agonist. The inward current 
evoked by an equivalent concentration of muscimol, however, was typ- 
ically larger in amplitude. The whole-cell capacitance was 100 pE B, 
Inward currents were evoked by rapid application of 50 FM GABA and 
could be reversibly depressed by coapplication the GABA, receptor 
antagonist bicuculline (10 PM). The whole-cell capacitance was 98 pE 
C, Inward currents were evoked by rapid application of 50 FM GABA 
and could be reversibly depressed by coapplication the Cl- channel 
blocker picrotoxin (10 FM). The whole-cell capacitance was 55 pE 
pyramidal neurons were depressed consistently by coapplication 
of DMCM (44 ? 5%, range 33-56%, n = 7; Fig. 5E). These 
experiments suggest that astrocytic GABA receptors share sim- 
ilarities with, but are not identical to, neuronal GABA, recep- 
tors. 
GABA-induced Ca2+ responses 
GABA-induced changes of intracellular Ca*+ were analyzed in 
acutely isolated astrocytes using the AM form of indo-l and 
standard fluorometric techniques. Bath superfusion of GABA (1 
mM) caused a transient increase in [CaZ+], in 30% of the astro- 
cytes tested (n = 11/33; Fig. 6). At rest, the ratio (R) of the 
fluorescence intensities at two wavelengths (405 nml485 nm) 
was 0.37 ? 0.04 (n = 11). Application of GABA increased the 
ratio to 0.41 + 0.5 (n = 11). These values corresponded to an 
average increase in [Ca*+], from 172 nM in control to 296 nM 
in the presence of GABA. Increasing external K+ from control 
levels of 5 mM to 50 mu also increased [Ca”], by opening 
verapamil-sensitive voltage-activated Ca2+ channels (Fig. 6A; 
Duffy and MacVicar, 1994). To investigate the possibility that 
GABA also increased [CaZ+], by influx through voltage-activated 
Ca2+ channels secondary to a GABA,-induced membrane de- 
polarization, the sensitivity of GABA-evoked [CaZ+], changes to 
verapamil and picrotoxin was examined. The Ca*+ channel 
blocker verapamil (150 pM) reversibly depressed the GABA- 
induced increase in [Ca*+], (n = 2; Fig. 6B). Verapamil did not 
have an inhibitory effect, however, on the magnitude of the 
whole-cell GABA-activated current (data not shown; n = 5). 
Picrotoxin (100 FM), which specifically blocks Cl- channels, 
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Figure 5. Modulation of the astrocytic GABA receptor by barbiturate 
and benzodiazepine receptor ligands. Al, A control inward current 
evoked by rapid application of 50 PM GABA. Coapplication of 50 FM 
GABA with 25 IJ,M of the barbiturate sodium pentobarbital reversibly 
potentiated the GABA-evoked current. The whole-cell capacitance was 
72 pE A2, Control currents elicited by 50 PM GABA could be reversibly 
potentiated by coapplication of 10 FM diazepam, a benzodiazepine re- 
ceptor modulator. The whole-cell capacitance was 65 pE A3, In a sub- 
population of astrocytes (20%), inward currents evoked by 50 FM 
GABA could be reversibly enhanced by coapplication of 10 FM 
DMCM, a benzodiazepine inverse agonist. The whole-cell capacitance 
was 65 pE A4, In the remainder of astrocytes (80%), coapplication of 
10 pM DMCM resulted in a depression of the GABA-activated current. 
The whole-cell capacitance was 56 pE B, For comparison, reversible 
depression of a neuronal (CA1 pyramidal) inward current by DMCM 
is illustrated. The whole-cell capacitance was 16 pE C, A summary of 
the benzodiazepine actions on GABA-activated currents from acutely 
isolated astrocytes (astro) and CA1 pyramidal neurons (neurons). 
reversibly depressed the GABA-induced increase in [Ca*+], (n 
= 2; Fig. 6C). 
Antibodies and Western blotting 
Several antibodies were prepared that specifically recognized the 
GABA, receptor complex and its subunits at the immunoblot 
and immunocytochemical level (Gu et al., 1992, 1993; Perez- 
Velazquez and Angelides, 1993). Antibody 967 (PAb-967), gen- 
erated against the affinity-purified GABA,/benzodiazepine re- 
ceptor of rat brain, recognized two closely spaced 
immunoreactive bands in the 52-56 kDa molecular mass range 
(Fig. 7A, lane 2). These bands corresponded to the predicted 
molecular mass for the population of GABA, receptor subunits 
(LX, 48-53 kDa; p, 55-57 kDa) and the migration of these sub- 
units in this 4-15% linear polyacrylamide gradient gel system. 
The immunodetection of the GABA, receptor subunits is spe- 
cific since preimmune IgG from the same rabbit, 967, (Fig. 7A, 
lane 1) did not show any immunoreactivity. PAb-967 also did 
not show any immunoreactivity toward proteins extracted from 
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Figure 6. Activation of voltage-dependent Ca*+ channels in astrocytes 
by a GABA-evoked Cl- efflux and subsequent depolarization. A, Su- 
perfusion of 1 mM GABA causes a transient increase in [Ca2+],. For 
comparison, a transient increase in [CaZ+], evoked by superfusion of 50 
mM K+. B, For control, a transient increase in [Caz+], was evoked by 
superfusion of 1 mM GABA. Coperfusion of 1 rn~ GABA and 150 FM 
verapamil, a Ca*+ channel blocker, reversibly depressed the GABA- 
evoked increase in [Caz+],. C, A transient increase in [Cap+],, evoked 
by superfusion of 1 mM GABA, was reversibly depressed by coperfu- 
sion of the Cl- channel blocker picrotoxin (100 PM). 
red blood cells (data not shown), indicating that the recognitions 
of polypeptides in brain extracts was specific and represented 
the different components of the GABA, receptor. In addition, 
PAb-967 specifically recognized GABA, receptors in hippocam- 
pal cells in culture and in slices (data not shown) in a pattern 
that overlaid that of fluorescent benzodiazepine staining (Velaz- 
quez et al., 1989). PAb-967, however, did not immunoprecipitate 
3H-flunitrazepam binding sites from solubilized brain mem- 
branes. 
Peptides corresponding to several regions of the GABA, re- 
ceptor were synthesized as antigens in order to prepare se- 
quence- and subunit-specific antibodies. Of the four that were 
injected, only two of the anti-peptide antibodies were positive 
in dot blots and Western blotting. These anti-peptide antibodies, 
generated against the (Y, subunit C-terminus (PAb-B) and p, sub- 
unit N-terminus (PAb-Q) of the GABA, receptor, recognized 
polypeptides at apparent molecular masses of 50 kDa (Fig. 7B, 
lane 2, C, lane 3) and 55 kDa (Fig. 7B, lane 4, C, lane 5), 
respectively. These molecular masses corresponded precisely to 
those predicted from the amino acid sequence encoded in the 
cDNA of these subunits in rat brain. The specificity of the rec- 
ognition is shown by the absence of immunoreactivity of the 
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Figure 7. Immunoblots of three primary antibodies and their preimmune sera to purified GABA, receptors and crude glycoproteins from rat brain. 
A, Immunoblots with a polyclonal antibody generated against GABA,/benzodiazepine receptors (PAb-967). A 4-15% linear polyacrylamide gel 
was loaded with 5-10 pg of benzodiazepine affinity-purified GABA, receptor from rat brain. Lane 1, Preimmune IgG; lane 2, immune IgG fraction. 
Dilutions of the antibodies were 1:50. B, Immunoblots with antibodies generated against either cx, (PAb-B) or p1 (PAb-Q) subunit peptides of the 
GABA, receptor. A 7.5% polyacrylamide gel was loaded with lo-20 (*g of a crude glycoprotein preparation from rat brain. The 3H-flunitrazepam- 
specific binding of the WGA eluent was 6.2 pmol/mg protein. Lanes I, 2, Preimmune and immune serum for the antibody generated against the 
C-terminal peptide of the 0~~ subunit. Lanes 3, 4, Preimmune and immune serum for the antibody generated against the N-terminal peptide of the 
l3, subunit. Dilutions of the antisera were 1:50. C, Immunoblots with antibodies directed against either 01, or l3, subunit peptides of the GABA, 
receptor. A 7.5% polyacrylamide gel was loaded with 5-10 p,g of benzodiazepine affinity-purified GABA, receptor from rat brain. Specific ?H- 
flunitrazepam binding was 70 ? 10 pmol/mg protein. Lune I, Silver-stained gel loaded with the purified GABA, receptor. Lanes 2, 3, Preimmune 
and immune IgG fractions for the antibody generated against the C-terminal peptide of the ~1, subunit. Lanes 4, 5, Preimmune and immune IgG 
fractions for the antibody generated against the N-terminal peptide of the p, subunit. Dilutions of the IgG fractions were 1:50. 
preimmune IgG from each of the antibodies used (Fig. 7B, lanes 
1, 3; C, lanes 2, 4). Further studies with the anti-peptide anti- 
bodies showed that, while they were not able to immunoprecip- 
itate GABA, receptors from solubilized rat brain membranes, 
immunoblot and immunocytochemical analysis of both (Y,- and 
p,-transfected cells showed specific and high-affinity staining 
(Perez-Velazquez and Angelides, 1993). It is unlikely that 
PAb-B recognized additional cx subunit isoforms (e.g., (Y*& since 
the peptide sequence was entirely specific for the (Y, variant. It 
is possible that PAb-Q may have cross-reacted with the l3, and 
p3 variants, considering the degree of homology between the 
N-termini of the p subunits (Ymer et al., 1989), although we 
have no evidence for such cross-reactivity. 
Immunocytochemical evidence for GABA, receptor expression 
The expression and localization of GABA, receptors was deter- 
mined by dual labeling acutely isolated astrocytes with a mono- 
clonal antibody against GFAP (MAb-GFAP) and one of three 
polyclonal antibodies which recognize the GABAJbenzodiaze- 
pine receptor (PAb-967), an IX, subunit peptide (PAb-B), or a p, 
subunit peptide (PAb-Q). PAb-967, which recognizes multiple 
GABA, subunit isoforms, localized immunoreactivity on the as- 
trocytic cell body and most large processes (Fig. 8A). In contrast, 
antibodies generated against either an (Y, subunit peptide (PAb- 
B; Fig. 8B) or a l3, subunit peptide (PAb-Q; Fig. 8C) localized 
immunoreactivity predominantly on a distinct subset of process- 
es. Pyramidal and fusiform neurons coisolated with astrocytes 
displayed intense labeling along the plasma membrane of both 
the soma and proximal dendrites (data not shown). The intensity 
of fluorescence was considerably greater for neurons than astro- 
cytes. Control experiments in which the cells were incubated 
with preimmune sera did not display immunoreactivity (Fig. 
80). In addition, the immunoreactive product on astrocytes was 
similar whether the MAb-GFAP was present or omitted, sug- 
gesting that cross-reactivity between primary antibodies did not 
underlay the staining patterns. 
Benzodiazepine binding on live astrocytes 
The distribution of central GABA,/benzodiazepine receptors on 
live astrocytes was determined by applying 5 nM of the fluores- 
cent benzodiazepine derivative Ro 7-1986-BODIPY (Velazquez 
et al., 1989; McCabe et al., 1990). Total binding, revealed by 
laser-scanning confocal microscopy, was distributed in discrete 
clusters on both the cell body and a subset of processes (n = 
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1 l/l 1; Fig. 9B). Competitive displacement of specific binding 
by coperfusion of 500 nM diazepam revealed nonspecific bind- 
ing (Fig. SC). The average pixel intensity decreased by 77 ? 
3% (range 64-88%, n = 11). In agreement with previous find- 
ings, specific binding on neurons was greatest on the soma with 
the fluorescence intensity tapering toward distal dendrites (data 
not shown; Velazquez et al., 1989). The pixel intensity on neu- 
rons was typically twofold greater than astrocytes, indicating 
higher benzodiazepine receptor density. Control experiments 
with either plasma membrane (DiI, IZ = 3; Nile red, IZ = 2) or 
lectin (concanavalin-A-tetramethylrhodamine; II = 3) markers 
revealed homogeneous fluorescence across the entire astrocytic 
membrane, indicating that fluorescent benzodiazepine hot spots 
were not due to excessive membrane folding or glycoprotein 
aggregation, respectively (data not shown; Velazquez et al., 
1989). At the completion of experiments, a subpopulation of 
cells was fixed and immunostained for GFAP to verify its astro- 
cytic phenotype (n = 515; Fig. 9D). 
Discussion 
The results of this study demonstrate that noncultured astrocytes 
from the mature rat hippocampus express abundant GABA, re- 
ceptors. Analysis of benzodiazepine pharmacology indicates that 
astrocytic GABA, receptors are both heterogeneous among the 
astrocyte population and distinct from neuronal receptors. Ac- 
tivation of GABA, receptors in astrocytes results in an efflux of 
Cl- which can significantly depolarize these cells to a potential 
at which voltage-gated Ca*+ channels open. Moreover, the data 
show that astrocytes, like neurons, target GABA, receptors and 
subunits to distinct cellular locations. 
Electrophysiology 
The GABA-activated Cl- channel in cultured astrocytes has 
been shown to be similar to the neuronal GABA, channel (Blan- 
kenfeld and Kettenmann, 1992; Fraser et al., 1994). The present 
work indicates that acutely isolated astrocytes also have a 
GABA receptor coupled to a Cl- channel. The GABA-activated 
Cl- current was depressed by the GABA, receptor antagonist 
bicuculline and mimicked by muscimol, a selective GABA, re- 
ceptor agonist. Moreover, the current had a reversal potential 
close to the Cl- equilibrium potential and was depressed by the 
Cll channel blocker picrotoxin. 
The astrocytic current evoked with a saturating concentration 
of GABA (1 mM) was one-half the amplitude of the current 
recorded under identical conditions in neurons. The whole-cell 
capacitance of astrocytes was typically fivefold larger than neu- 
rons, suggesting that average receptor density on neurons is con- 
siderably greater than on astrocytes. Nonetheless, GABA, re- 
ceptor activation on astrocytes in vivo could evoke a substantial 
Cll efflux and localized membrane depolarization, since it is 
likely that the true current amplitude was underestimated. For 
example, the complex morphology of astrocytes and uneven dis- 
tribution of receptors along the membrane undoubtedly compro- 
mised space-clamp control. In addition, enzymatic treatment 
with papain has been reported to abolish inhibitory postsynaptic 
potentials, suggesting proteolytic digestion of the receptor/chan- 
nel complex (McCarren and Alger, 1987). 
Recombinant studies have revealed that (Y subunit expression 
controls GABA receptor sensitivity (Levitan et al., 1988). Dose- 
response analysis of acutely isolated cells demonstrated that the 
ED,, was different between CA1 pyramidal neurons and astro- 
cytes. The ED,, for pyramidal neurons (14 pM) was similar to 
recombinant receptors containing the (Y, subunit, whereas the 
ED,, for astrocytes (50 FM) is compatible with 01~ expression 
(Levitan et al., 1988). Caution must be exercised in interpreta- 
tion of these results, however, since the whole-cell current is 
probably derived from multiple subunit combinations. Indeed, 
(Y, immunoreactivity on astrocytic processes was demonstrated 
in this study. 
Functional expression of cloned subunits in combination with 
electrophysiological assays has demonstrated that the c@ subunit 
combination is sufficient for modulation by barbiturates (Scho- 
field et al., 1987). Benzodiazepine modulation, however, requires 
the addition of a third subunit from the y subfamily (Pritchett 
et al., 1989). In acutely isolated astrocytes, the GABA-activated 
inward current was modulated by barbiturate and benzodiaze- 
pine receptor ligands. Pentobarbital and diazepam potentiated 
the GABA-induced whole-cell current. These data are consistent 
with previous reports for cultured astrocytes (Bormann and Ket- 
tenmann, 1988; Rosewater and Sontheimer, 1994), cultured oli- 
godendrocytes (Blankenfeld et al., 1991), and both cultured and 
acutely isolated neurons (e.g., Ransom and Barker, 1976; Ka- 
neda et al., 1989; Twyman et al., 1989; Yakushiji et al., 1989). 
Both compounds increase the mean channel open time: barbi- 
turates by increasing open duration and diazepam by increasing 
the frequency of opening (Twyman et al., 1989). 
The benzodiazepine inverse agonist DMCM is known to de- 
press the GABA-activated current in oligodendrocytes (Blan- 
kenfeld et al., 1991), neurons (Bormann et al., 1985; Puia et al., 
1989; Bovolin et al., 1992), chromaffin cells (Bormann and Ket- 
tenmann, 1988), and a subpopulation of cultured astrocytes ob- 
tained from spinal cord (“fibrous”; Rosewater and Sontheimer, 
1993). The compound decreased channel opening frequency, 
without altering conductance or opening duration (Vicini et al., 
1987). In contrast, DMCM enhances the GABA-activated cur- 
rent in cultured astrocytes obtained from cortex (Backus et al., 
1988; Bormann and Kettenmann, 1988), cerebellum (Bovolin et 
al., 1992), and spinal cord (“protoplasmic”; Rosewater and Son- 
theimer, 1993). Indeed, cultured astrocytes from cerebellum ex- 
press high levels of the y, subunit (Bovolin et al., 1992) which 
has been associated with DMCM enhancement of GABA-acti- 
vated currents in recombinant studies (Puia et al., 1991). In 20% 
of acutely isolated astrocytes, DMCM also enhanced the GABA- 
activated current, suggesting that these GABA, receptors ex- 
press similar subunit combinations. In the remaining 80% of 
astrocytes DMCM depressed the GABA responses, suggesting 
that an alternative y subunit isoform was expressed. Interesting- 
ly, the DMCM-induced depression in astrocytes was less than 
one-half the depression observed in pyramidal neurons. The dif- 
ferential benzodiazepine pharmacology suggests subunit 
heterogeneity between not only astrocytes and neurons, but also 
within the astrocytic population. 
GABA-activated Caz+ influx 
The increase in [Ca2+li induced by GABA could potentially oc- 
cur through two mechanisms: influx through voltage-gated Ca2+ 
channels (MacVicar, 1984) and/or release from intracellular 
stores (Nilsson et al., 1993). Our finding that the GABA-acti- 
vated increase in [Ca*+], was inhibited in the presence of either 
the Ca*+ channel blocker verapamil or the Cllchannel blocker 
picrotoxin points to the former explanation. Verapamil did not 
diminish the GABA-activated current recorded in whole-cell 
mode; moreover, the presence of verapamil-sensitive Ca*+ chan- 
nels has been demonstrated previously (Duffy and MacVicar, 
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Figure 8. Digital micrographs of acutely isolated hippocampal astrocytes illustrating dual labeling for glial fibrillary acidic protein (MAb-GFAP) 
and either GABAJbenzodiazepine receptors (GABA,) or individual subunit peptides (a, or p,). A, GFAP-positive astrocytes react with antisera 
1994). The Ca*+ influx, therefore, was mediated by GABA,- 
induced membrane depolarization. 
The indo- 1 experiments provide clues as to the magnitude and 
polarity of the membrane potential response to GABA. This 
could not be determined under whole-cell voltage clamp since 
the cell interior is dialyzed and the Cl- gradient artificially dis- 
torted. The threshold for activating Ca2+ influx in acutely iso- 
lated astrocytes is reached when external K+ is increased to 20 
mM corresponding to a depolarization of approximately -45 mV 
(Duffy and MacVicar, 1994). These data indicate that GABA 
must depolarize the cell membrane to at least this potential, sup- 
porting previous studies suggesting that the Cl- reversal poten- 
tial in astrocytes is positive to resting potential (Kimelberg and 
Frangakis, 198.5; Kettenmann et al., 1987). 
Astrocytes in vivo are coupled extensively by gap junctions 
(Ransom and Carlini, 1986) and maintain a significant K+ per- 
meability at the resting membrane potential (Walz, 1989). 
Whether local depolarization by GABA could attain the acti- 
vation threshold for Ca*+ channel opening in vivo is speculative, 
but may occur under certain conditions. For example, a constric- 
tion in the diameter of a process and clustering of the GABA, 
receptorlionophore in close association with Ca2+ channels 
would facilitate local depolarization and Ca2+ channel activation. 
Furthermore, conditions which alter membrane and gap junction 
resistance (e.g., neurotransmitter modulation) could facilitate this 
event. 
Subcellular localization of GABA, receptors 
Until recently, immunocytochemical studies have generally 
failed to identify GABA, receptor expression in astrocytes (re- 
viewed by Fraser et al., 1994). This lack of evidence may be 
due to lower levels of receptor expression making detection in 
tissue sections difficult. Indeed, the absolute amount of GABA, 
subunit mRNA expressed by astrocytes was two orders of mag- 
nitude less than neurons when quantified by competitive poly- 
merase chain reaction (Bovolin et al., 1992). A lower expression 
of receptors is also consistent with our electrophysiological and 
anatomical assays. The antibody staining reported here is prob- 
ably due to the increased resolution available with isolated cells 
in combination with the antigens chosen for antibody production 
(Gu et al., 1992, 1993; Perez-Velazquez and Angelides, 1993). 
Our data suggests that at least some astrocytic receptors may 
include the ct, p, subunit combination, together with an unknown 
isoform of the y subunit. 
The specificity of the antibody staining in this study can be 
inferred by several observations: (1) purified receptors or sub- 
unit-specific peptide sequences were used as antigens; (2) selec- 
tive recognition of subunit(s) from either crude glycoproteins or 
purified GABA, receptors on Western blots; (3) good correlation 
between immunoreactive patterns and fluorescence binding as- 
says; (4) good correlation between neuronal staining and pre- 
viously reported patterns; and (5) lack of staining with preim- 
mune sera. 
t 
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The immunoreactive patterns observed within hippocampal 
astrocytes suggests single-cell heterogeneity. Polyclonal anti- 
body 967, which recognizes several subunits and possibly their 
isoforms, localized receptors to the cell body and a subset of 
processes. Cytoplasmic staining was observed, in agreement 
with previous immunocytochemical studies on astrocytes (Gu et 
al., 1993; Rosier et al., 1993), which may reflect receptor trans- 
port and/or turnover (Somogyi et al., 1989; Zimprich et al., 
1991; Thompson et al., 1992). Polyclonal antibodies generated 
against either (Y, or p, subunit peptides revealed localization pre- 
dominantly on astrocytic processes. Taken together, these data 
suggest GABA, subunits may be distributed differentially within 
single astrocytes. Perhaps the (Ye subunit, whose expression is 
suggested by our electrophysiological data, may be localized on 
the cell body which is typically devoid of CX, subunit immuno- 
reactivity. The GABA, receptors on the cell body may contain 
a p subunit other that the p, isoform (e.g., &), since PAb-967 
and PAb-Q have been reported previously to recognize different 
subunits (Gu et al., 1993), or, alternatively, simply may not con- 
tain a p subunit (Fritschy et al., 1992). Interestingly, a mono- 
clonal antibody generated against a similar portion of the p, 
subunit N-terminus resulted in similar staining of cerebral astro- 
cytes that was distinct from the pz and p3 isoform distribution 
(Rosier et al., 1993). A nonrandom distribution of subunits has 
been reported recently for neurons (Fritschy et al., 1992). Given 
the number of subunits identified, many combinations are pos- 
sible which form a functional receptor. Recent evidence, how- 
ever, would suggest that subunits assemble into preferred com- 
binations (Angelloti et al., 1993). In fact, a single subunit 
combination may predominate in a particular cell (Fritschy et 
al., 1992) and subunit assembly may then determine cellular 
sorting (Perez-Velaquez and Angelides, 1993). In astrocytes, the 
01, and p, subunits may colocalize in a single receptor and there- 
by be targeted to distinct processes. 
The benzodiazepine Ro 7-1986, which has high affinity and 
selectivity for central GABA, receptors (Gavish and Snyder, 
1981), has been used previously for fluorescent ligand binding 
assays on membrane fractions and live cells (Valequez et al., 
1989; McCabe et al., 1990). On live astrocytes, membrane- 
bound receptors were segregated into discrete patches on the cell 
body and distal processes. This observation is consistent with 
the immunoreactive findings and supported by previous studies 
on cultured astrocytes indicating an uneven distribution of GA- 
BA, receptors along the plasma membrane (Bormann and Ket- 
tenmann, 1988; Ventimiglia et al., 1990). GABA, receptors clus- 
tered on astrocytic processes may be in close proximity to 
inhibitory synapses, as has been recently demonstrated for Berg- 
mann glial cells (Miiller et al., 1994). Surprisingly, a high den- 
sity of receptors are localized on the cell body. These receptors 
may be activated by neuronally released GABA, flowing out of 
the synaptic cleft, or alternatively by GABA release from adja- 
cent astrocytes (Sarthy, 1985). 
raised against GABA, receptors affinity purified on a benzodiazepine column (PAb-967). Note the punctate staining on the cell body (double arrow) 
and on numerous larger processes (single arrow). B, GFAP-positive astrocytes react with antisera generated against the cq subunit C-terminal peptide 
(PAb-B). Note that the staining is pronounced in a select subset of processes (single arrow). The cell body, marked by the double arrow, had weak 
levels of immunoreactivity. C, GFAP-positive astrocytes react with antisera generated against the p, subunit N-terminal peptide (PAb-Q). Note that 
the staining is pronounced in a select subset of processes (single arrow). The cell body, marked by the double arrow, was devoid of immunoreactivity. 
D, Staining was not observed on GFAP-positive astrocytes following substitution of the PAbs with their respective preimmune sera. In this example, 
PAb-967 was substituted with preimmune from rabbit-967. 
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Figure 9. Subcellular localization of central benzodiazepine receptors on an acutely isolated astrocyte by use of a fluorescent benzodiazepine 
derivative. A, A digital photomicrograph of an acutely isolated hippocampal astrocyte. B, Areas of intense fluorescence indicate the subcellular 
expression of GABAJbenzodiazepine receptors. The receptors are located on both the cell body (double arrow) and on several larger processes 
(single arrows). The black/white scale bar represents increasing fluorescence intensity (“?F). Fluorescent localization of benzodiazepine receptors 
was determined following a 20 min incubation in 5 nM of the derivative. C, Nonspecific binding was determined following coperfusion of 500 nM 
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Consequence of GABA receptor activation in the astrocytes 
The physiological significance of astrocytic GABA, receptor ac- 
tivation remains speculative; however, [Cl-], and [pH], homeo- 
stasis have been suggested (reviewed by Fraser et al., 1994). For 
example, a GABA-evoked Cl- efflux from astrocytes could buff- 
er [Cl-], in the vicinity of GABAergic synapses (Borrnann and 
Kettenmann, 1988; MacVicar et al., 1989). The GABA, recep- 
tor/ionophore is also permeable to HCO,- ions (Bormann, 1988) 
which may underlie the extracellular alkalinization observed 
during inhibitory activity (Chesler and Chen, 1991; Kaila et al., 
1991, 1992). Extracellular alkalinization augments presynaptic 
Ca*+ channels and thereby enhances neurotransmitter release 
(Barnes et al., 1993). In addition, elevations in [HCO,-1, could 
augment [Cl-],, further by provoking anion exchange (Grover et 
al., 1993). Efflux of either anion could initiate Ca2+ influx via 
membrane depolarization and voltage-gated channels. As a con- 
sequence, astrocytes could respond to a GABA-induced eleva- 
tion in [Ca2+li by a change in morphology (filopodia extension; 
Cornell-Bell and Finkbeiner, 1991) or their metabolic 
(glycogenolysis; Ververken et al., 1982) and functional (GABA 
transport; Sarthy, 1983) states. The combination of GABA re- 
ceptors and Ca2+ channels, therefore, provide the appropriate 
tools for astrocytes to detect and respond to inhibitory neuronal 
activity. 
References 
Alvarez-Leemans FJ, Russel J (1990) Chloride channels and carriers 
in nerve, muscle and glial cells. New York: Plenum. 
Angelotti TP Uhler MD, Macdonald RL (1993) Assembly of GABA, 
receptor subunits: analysis of transient single-cell expression utilizing 
a fluorescent substrate/marker gene technique. J Neurosci 13: 141 S- 
1428. 
Backus KH, Kettenmann H, Schachner M (1988) Effect of benzodi- 
azepines and pentobarbital on the GABA-induced depolarization in 
cultured astrocytes. Glia 1: 132-140. 
Barnes S, Merchant V, Mahmud F (1993) Modulation of transmission 
gain by protons at the photoreceptor output synapse. Proc Nat1 Acad 
Sci USA 90:10081-10085. 
Barres BA, Chun LLY, Corey DP (1989) Calcium current in cortical 
astrocytes: induction by CAMP, neurotransmitters, and permissive ef- 
fect of serum factors. J Neurosci 9:3169-3175. 
Berger T, Walz W, Schnitzer J, Kettenmann H (1992) GABA- and 
glutamate-activated currents in glial cells of the mouse corpus cal- 
losum slice. J Neurosci Res 31:21-27. 
Blankenfeld G, Kettenmann H (1992) Glutamate and GABA receptors 
in vertebrate glial cells. Mol Neurobiol 5:31-43. 
Blankenfeld G, Trotter J, Kettenmann H (1991) Expression and devel- 
opmental regulation of a GABA, receptor in cultured murine cells 
of the oligodendrocyte lineage. Eur J Neurosci 3:3 1 O-3 16. 
Bormann J (1988) Electrophysiology of GABA, and GAB A, receptor 
subtypes. Trends Neurosci 11: 112-l 16. 
Bormann J, Clapham DE (1985) y-aminobutyric acid receptor channels 
in adrenal chromaffin cells: a patch-clamp study. Proc Nat1 Acad Sci 
USA 82:2168-2172. 
Bormann J, Kettenmann H (1988) Patch clamp study of GABA recep- 
tor Cl- channels in cultured astrocytes. Proc Nat1 Acad Sci USA 85: 
9336-9340. 
Bormann .I, Ferrer0 P, Guidotti A, Costa E (1985) Neuropeptide mod- 
ulation of GABA-receptor Cl- channels. Regul Pept [Suppl] 4:33- 
38. 
Bovolin P, Santi MR, Puia G, Costa E, Grayson D (1992) Expression 
patterns of y-aminobutyric acid type A receptor subunit mRNAs in 
t 
primary cultures of granule neurons and astrocytes from neonatal rat 
cerebella. Proc Nat1 Acad Sci USA 89:9344-9348. 
Burt DR, Kamatchi GL (1991) GABA, receptor subtypes: from phar- 
macology to molecular biology. FASEB J 5:2916-2923. 
Chesler M, Chen JCT (1991) Alkaline extracellular pH shifts generated 
by two transmitter dependent mechanisms. Can J Physiol Pharmacol 
7O:S286-S292. 
Chow TP, DeGrado WE Knight E (1984) Antibodies to synthetic pep- 
tides of human interferon B. J Biol Chem 259:12220-12225. 
Clark B, Mobbs P (1992) Transmitter-operated channels in rabbit ret- 
inal astrocytes studied in situ by whole-cell patch clamping. J Neu- 
rosci 6:2857-2863. 
Cornell-Bell AH, Finkbeiner SM (1991) Ca2+ waves in astrocytes. Cell 
Calcium 12: 185-204. 
Duffy S, MacVicar BA (1994) Potassium-evoked Caz+ influx in acutely 
isolated hippocampal astrocytes. Neuroscience 61:5 1-61. 
Fraser DD, MacVicar BA (1991) Low-threshold transient calcium cur- 
rent in rat hippocampal lacunosum-moleculare interneurons: kinetics 
and modulation bv neurotransmitters. J Neurosci 11:28 12-2820. 
Fraser DD, Duffy S: Hoppe D, Kettenmann H, MacVicar BA (1992) 
GABA-activated Cl- current and Ca2+ influx in acutely isolated hip- 
pocampal astrocytes. Can J Physiol Pharmacol 70:Aix. 
Fraser DD, Angelides KJ, MacVicar BA (1993) Subcellular localiza- 
tion of GABA, receptors on astrocytes using polyclonal antibodies 
and a fluorescent benzodiazepine derivative. Int Union Physiol Sci 
321244.30. 
Fraser DD, Mudrick-Donnon LA, MacVicar BA (1994) Astrocytic 
GABA receptors. Glia 11:83-93. 
Fritschy JM, Benke D, Mertens S, Oertel WH, Batchi T, Mohler H 
(1992) Five subtypes of type A y-aminobutyric acid receptors iden- 
tified in neurons by double and triple immunofluorescent staining 
with subunit-specific antibodies. Proc Nat1 Acad Sci USA 89:6726- 
6730. 
Gavish M, Snyder SH (198 1) y-aminobutyric acid and benzodiazepine 
receptors: copurification and characterization. Proc Nat1 Acad Sci 
USA 78:1939-1942. 
Gitman AG, Kahane I, Loyter A (1985) Use of virus-attached antibod- 
ies or insulin molecules to mediate fusion between sendai virus en- 
velopes and neuraminidase-treated cells. Biochemistry 24:2762- 
2765. 
Grover LM, Lambert NE, Schwartzkroin PA, &yler TJ (1993) Role of 
HCO,- ions in depolarizing GABA, receptor-mediated responses in 
pyramidal cells of rat hippocampus. J Neurophysiol 69:1541-1555. 
Grynkiewics G, Poenie M, Tsien RY (1985) A new generation of Ca2+ 
indicators with greatly improved fluorescence properties. J Biol Chem 
260:3440-3450. 
Gu Q, Velazquez JLP, Angelides KJ, Cynader MS (1992) GABA, re- 
ceptor immunoreactivity in the white-matter. Neuroreport 3: 169-172. 
Gu Q, Velazquez JLP Angelides KJ, Cynader MS (1993) Immunocy- 
tochemical study of GABA, receptors in the cat visual cortex. J 
Comp Neurol 333:94-108. 
Hoppe D, Kettenmann H (1989) GABA triggers a Cl- efflux from 
cultured mouse olinodendrocvtes. Neurosci Lett 97:334-339. 
Kaila K, Panula P, Kayhunen T, Heinonen E (1991) Fall in intracellular 
pH mediated by GABA, receptors in cultured rat astrocytes. Neurosci 
Lett 126:9-12. 
Kaila K, Paalasmaa P, Taira T, Voipio J (1992) pH transients due to 
monosynaptic activation of GABA, receptors in rat hippocampal slic- 
es. Neuroreport 3: 105-108. 
Kaneda M, Wakamori M, Akaike N (1989) GABA-induced chloride 
current in rat isolated purkinje cells. Am J Physiol 256:C1153-1159. 
Kay A, Wong RKS (1986) Isolation of neurons suitable for patch- 
clamping from adult mammalian central nervous system. J Neurosci 
Methods 16:227-238. 
Kettenmann H (1990) Chloride channels and carriers in cultured glia 
cells. In: Chloride channels and carriers in nerve, muscle, and glial 
cells (Alvarez-Leefmans FJ, Russell JM, eds), pp 193-208. New 
York: Plenum. 
diazepam with the fluorescent benzodiazepine derivative for 20 min. The majority of benzodiazepine receptor labeling was competitively displaced. 
The fluorescent image was obtained under identical optical conditions, as in B. D, At the completion of the experiment, the cell was fixed and 
immunostained for GFAP to verify its astrocytic phenotype. 
2732 Fraser et al:GABA/Benzodiazepine Receptors in Astrocytes 
Kettenmann H, Schachner M (1985) Pharmacological properties of 
GABA, glutamate and aspartate induced depolarizations in cultured 
astrocytes. J Neurosci 5:3295-3301. 
Kettenmann H, Backus BH, Schachner M (1987) y-aminobutyric acid 
opens Cl-channels in cultured astrocytes. Brain Res 404:1-9. 
Kimelberg HK (1990) Chloride transport across glial membranes. In: 
Chloride channels and carriers in nerve, muscle, and glial cells (Al- 
varez-Leefmans FJ, Russell JM, eds), pp 159-191. New York: Ple- 
num. 
Kimelberg HK, Frangakis MV (1985) Furosemide- and bumetanide- 
sensitive ion transport and volume control in primary astrocyte cul- 
tures from rat brain. Brain Res 61:125-134. 
Kirchhoff E Kettenmann H (1992) GABA triggers a [Caz+], increase 
in murine precursor cells of the oligodendrocyte lineage. Eur J Neu- 
rosci 4:1049-1058. 
Laemmli K (1970) Cleavage of structural proteins during the assembly 
of the head of bacteriophage T4. Nature 277:680-685. 
Levitan ES, Schofield PR, Burt DR, Rhee LM, Wisden W, Kohler M, 
Fujita N, Rodriguez N, Stephenson FA, Darlison MG, Barnard EA, 
Seeburg PH (1988) Structural and functional basis for GABA, re- 
ceptor heterogeneity. Nature 335:76-79. 
MacVicar BA (1984) Voltage-dependent CaZ+ channels in glial cells. 
Science 226:1345-1347. 
MacVicar BA, Tse FWY (1988) Norepinephrine and cyclic adenosine 
3’:5’-cyclic monophosphate enhances a nifedipine-sensitive calcium 
current in cultured rat astrocytes. Glia 1:359-365. 
MacVicar BA, Tse FWY, Crichton SW, Kettenmann H (1989) GABA- 
activated Cl- channels in astrocytes of hippocampal slices. J Neurosci 
9:3577-3583. 
MacVicar BA, Fraser DD, Duffy S (1992) Preparation of astrocytes: 
primary cell culture and acute isolation. In: Practical electrophysio- 
lo&al methods (Kettenman H. Grantvn R. eds). DD 101-104. New 
Y&k: Wiley-Liss: 
I. II 
McCabe RT, De Costa BR, Miller RL, Havunjian RH, Rice KC, 
Skolnick P (1990) Characterization of benzodiaiepine receptors with 
fluorescent ligands. FASEB J 4:2934-2940. 
McCarren M, iger B (1987) Papain effects on rat hippocampal neu- 
rons in the slice preparation. Neurosci Lett 78:307-310. 
Mudrick-Donnon LA, Williams PJ, Pittmann QP, MacVicar BA (1993) 
Postsynaptic potentials mediated by GABA and dopamine evoked in 
stellate glial cells of the pituitary pars intermedia. J Neurosci 13: 
4660-4666. 
Miiller T, Fritschy JM, Grosche J, Pratt GD, MGhler H, Kettenmann H 
(1994) Developmental regulation of voltage-gated K+ channels and 
GABA, receptor expression in Bergmann glial cells. J Neurosci 14: 
2503-25 14. 
Nilsson M, Eriksson PS, RGnnb%ck L, Hansson E (1993) GABA in- 
duces Ca*+ transients in astrocytes. Neuroscience 54:605-614. 
Olsen RW, Tobin AJ (1990) Molecular biology of GABA, receptors. 
FASEB J 4:1469-1480. 
Perez-Velazquez JL, Angelides KJ (1993) Assembly of GABA receptor 
subunits determines cellular sorting and localization in neurons. Na- 
ture 361:457-460. 
Peters A, Palay SL, Webster HD (1991) The fine structure of the ner- 
vous system. New York: Oxford UP. 
Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, Scho- 
field PR, Seeburg PH (1989) Importance of a novel GABA, receptor 
subunit for benzodiazepine pharmacology. Nature 338:582-585. 
Puia G, Santi MR, Vicini S, Pritchett DB, Seeburg PH, Costa E (1989) 
Differences in the negative allosteric modulation of y-aminobutyric 
acid receptors illicited by 4’-chlorodiazepam and by a P-carboline-3- 
carboxylate ester: a study with natural and reconstituted receptors. 
Proc Nat1 Acad Sci USA 86:7275-7279. 
Puia G, Vicini S, Seeburg PH, Costa E (1991) Influence of recombinant 
y-aminobutyric acid-A receptor subunit composition on the action of 
allosteric modulators of y-aminobutyric acid-gated Cl- currents. Mol 
Pharmacol 39:691-696. 
Ransom BR, Barker JL (1976) Pentobarbital selectively enhances 
GABA-mediated post-synaptic inhibition in tissue cultured mouse 
spinal neurons. Brain Res 114:530-535. 
Ransom BR, Carlini WG (1986) Electrophysiological properties of as- 
trocvtes. In: Astrocvtes (Fedoroff S, Vernadakis A, eds), PP 149. 
Orlando: Academic: 
__ 
Rosewater K, Sontheimer H (1994) Fibrous and protoplasmic astro- 
cytes express GABA, receptors that differ in benzodiazepine phar- 
macologi. Brain Res’&36:7?-80. 
_ _ 
Rosier A. Arckens L. Orban GA. Vandesande F (1993) Immunocvto- 
chemidal detection of astrocyte’GABA, receptors in cat visual co;tex. 
J Histochem Cytochem 41:685-692. 
Sarthy PV (1983) Release of [3H]y-aminobutyric acid from glial (mul- 
ler cells) of the rat retina: effects of K+, veratridine and ethylenedi- 
amine. J Neurosci 3:2494-2503. 
Schofield PR, Darlison MG, Fug&a N, Burt DR, Stephenson FA, Rod- 
riguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA, See- 
burg PH, Barnard EA (1987) Sequence and functional expression of 
the GABA, receptor show a ligand-Rated receptor superfamily. Na- 
ture 328:251-227. 
- -  ̂ _ 
Sigel W. Mamalaki C. Barnard EA (1982) Isolation of a GABA receo- 
‘ior from bovine brain using a beniodiazepine affinity column. FEB’S 
Lett 147:45-48. 
Somogyi P, Takagi H, Richards JG, Mijhler H (1989) Subcellular lo- 
calization of GABA,/benzodiazepine receptors in the cerebellum of 
rat, cat and monkey using monoclonal antibodies. J Neurosci 9:2197- 
2209. 
Steinhsuser C, Berger T, Frotscher M, Kettenmann H (1993) Voltage- 
and ligand-gated membrane current pattern of identifiable glial cells 
in the hippocampal slice. In: Slow activity changes in the brain (Has- 
chke W,&Speckmann EJ, eds), pp 179-190. Boston: Birkhguser. 
Steinhiuser C. Jabs R. Kettenmann H (1994) Prouerties of GABA and 
glutamate responses in identified gliai cells’of the mouse hippocampal 
slice. Hippocampus 4:19-36. 
Thompson CL, Bodewitz G, Stephenson FA, Turner JD (1992) Map- 
ping of GABA, receptors (Ye and 01~ subunit-like immunoreactivity in 
rat brain. Neurosci Lett 144:53-56. 
Towbin H, Stahelin T, Gordon J (1979) Electrophoretic transfer of pro- 
teins from polyacrylamide gels to nitrocellulose sheets: procedure-and 
some aunlications. Proc Nat1 Acad Sci USA 76:435C-4354. 
Tse FWY:I%aser DD, Duffy S, MacVicar BA (1992) Voltage-activated 
K+ channels in acutely isolated hippocampal astrocytes. J Neurosci 
12:1781-1788. 
Twyman RE, Rodgers CJ, Macdonald RL (1989) Differential regula- 
tion of y-aminobutyric acid receptor channels by diazepam and phen- 
obarbital. Ann Neurol 25:213-220. 
Velazquez JLP, Thompson CL, Barnes EM Jr, Angelides KJ (1989) 
Distribution and lateral mobility of GABA/benzodiazepine receptors 
on nerve cells. J Neurosci 9:2163- 2169. 
Ventimiglia R, Grierson JP, Gallombardo P, Sweetman PM, Tallman JF, 
Geller HM (1990) Cultured rat neurons and astrocytes express im- 
munologically related epitopes of the GABA,/benzodiazepine recep- 
tor. Neurosci Lett 115:131-136. 
Ververken D, Van Veldhoven P, Proost C, Carton H, De Wulf H (1982) 
On the role of Ca2+ ions in the regulation of glycogenolysis in mouse 
brain cortical slices. J Neurochem 38: 1286-1295. 
Vicini S, Mienville JM, Costa E (1987) Actions of benzodiazepine and 
P-carboline derivatives on y-aminobutyric acid Cl- channels recorded 
from membrane patches of neonatal rat cortical neurons in culture. J 
Pharmacol Exp Ther 243:1195-1201. 
Walz W (1989) Role of glia cells in the regulation of the brain ion 
microenvironment. Prog-Neurobiol 33:309-333. 
Yakushiii T, Tokutomi N. Akaike N (1989) Augmentation of GABA- 
induckd chloride current in frog sensory neur&s by diazepam. Neu- 
rosci Res 6:309-320. 
Ymer S, Schofield PR, Draguhn A, Werner P, KGhler M, Seeburg PH 
(1989) GABA, receptor p subunit heterogeneity: functional exires- 
sion of cloned cDNAs. EMBO J 8:1665-1670. 
Zimprich F, Zezula J, Sieghart W, Lassmann H (1991) Immunohisto- 
chemical localization of the cl,, ~1~ and 01~ subunit of the GABA, 
receptor in the rat brain. Neurosci Lett 127: 125-l 28. 
